GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » E10

Mesoblast (Mesoblast) E10 : $0.00 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Mesoblast E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mesoblast's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Mesoblast's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-28), Mesoblast's current stock price is $0.6051. Mesoblast's E10 for the quarter that ended in Dec. 2023 was $0.00. Mesoblast's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Mesoblast was 1.77. The lowest was 0.18. And the median was 0.82.


Mesoblast E10 Historical Data

The historical data trend for Mesoblast's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast E10 Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.11 0.90 1.47

Mesoblast Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.52 1.47 - -

Competitive Comparison of Mesoblast's E10

For the Biotechnology subindustry, Mesoblast's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesoblast's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mesoblast's Shiller PE Ratio falls into.



Mesoblast E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mesoblast's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/125.6559*125.6559
=0.000

Current CPI (Dec. 2023) = 125.6559.

Mesoblast Quarterly Data

per share eps CPI Adj_EPS
201306 0.000 95.473 0.000
201312 0.000 97.330 0.000
201406 -0.117 98.352 -0.149
201412 -0.082 99.002 -0.104
201503 -0.066 99.187 -0.084
201506 -0.087 99.838 -0.109
201509 -0.037 100.302 -0.046
201512 -0.059 100.673 -0.074
201603 -0.042 100.488 -0.053
201606 0.128 100.859 0.159
201609 -0.050 101.602 -0.062
201612 -0.049 102.159 -0.060
201703 -0.023 102.624 -0.028
201706 -0.060 102.809 -0.073
201709 -0.015 103.460 -0.018
201712 0.028 104.110 0.034
201803 -0.042 104.574 -0.050
201806 -0.042 104.945 -0.050
201809 -0.039 105.410 -0.046
201812 -0.047 105.967 -0.056
201903 -0.047 105.967 -0.056
201906 -0.039 106.617 -0.046
201909 -0.010 107.174 -0.012
201912 -0.044 107.917 -0.051
202003 -0.027 108.289 -0.031
202006 -0.058 106.246 -0.069
202009 -0.040 107.917 -0.047
202012 -0.042 108.846 -0.048
202103 -0.042 109.496 -0.048
202106 -0.032 110.332 -0.036
202109 -0.033 111.168 -0.037
202112 -0.038 112.654 -0.042
202203 -3.110 115.069 -3.396
202206 10.088 117.112 10.824
202209 -0.023 119.248 -0.024
202212 -0.031 121.477 -0.032
202303 -2.399 123.148 -2.448
202306 7.755 124.170 7.848
202309 0.000 125.656 0.000
202312 0.000 125.656 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Mesoblast  (OTCPK:MEOBF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Mesoblast was 1.77. The lowest was 0.18. And the median was 0.82.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mesoblast E10 Related Terms

Thank you for viewing the detailed overview of Mesoblast's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesoblast (Mesoblast) Business Description

Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.